Quickly Spot Consensus Among the World’s Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
2%
downside
4 price targets
|
0
%
|
|
|
|
2%
downside
4 price targets
|
0
%
|
|
|
|
2%
downside
14 price targets
|
0
%
|
|
|
1629
Immunovant
IMVT
$5.27B
|
2%
downside
3 price targets
|
0
%
|
|
|
2%
downside
4 price targets
|
0
%
|
|
|
|
2%
downside
4 price targets
|
0
%
|
|
|
|
2%
downside
7 price targets
|
0
%
|
|
|
|
2%
downside
6 price targets
|
0
%
|
|
|
|
2%
downside
8 price targets
|
0
%
|
|
|
|
2%
downside
11 price targets
|
0
%
|
|
|
1636
QuidelOrtho
QDEL
$1.99B
|
2%
downside
3 price targets
|
0
%
|
|
|
2%
downside
6 price targets
|
0
%
|
|
|
|
2%
downside
8 price targets
|
0
%
|
|
|
|
2%
downside
5 price targets
|
0
%
|
|
|
|
2%
downside
9 price targets
|
0
%
|
|
|
|
2%
downside
6 price targets
|
0
%
|
|
|
|
2%
downside
7 price targets
|
0
%
|
|
|
|
2%
downside
4 price targets
|
0
%
|
|
|
|
2%
downside
5 price targets
|
0
%
|
|
|
|
2%
downside
6 price targets
|
0
%
|
|
|
|
3%
downside
8 price targets
|
0
%
|
|
|
|
3%
downside
8 price targets
|
0
%
|
|
|
|
3%
downside
18 price targets
|
0
%
|
|
|
|
3%
downside
14 price targets
|
0
%
|
|
|
|
3%
downside
7 price targets
|
0
%
|
|